Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum Toxin Type A for Prevention of Hypertrophic Scars in Sternotomy Wounds
NCT02886988Phase 3Completed
- Sponsor
- Xijing Hospital
- Start
- Oct 2016
- Primary completion
- Dec 2017
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of botulinum toxin type A in Hypertrophic Scar (HS), sponsored by Xijing Hospital. Started Oct 2016; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
Hypertrophic Scar (HS)
Beyond the preview
Go deeper on NCT02886988.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02886988.